In recent years, vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) and their receptors have been the most significant angiogenic factors, the overexpression of which has been found in different subtypes of sarcomas, including angiosarcoma. This evidence concerns the gene VEGFA and angiosarcoma.